Education
About Us
Working with TipRanks
Follow Us
Janux Therapeutics Inc (JANX)
NASDAQ:JANX
Janx008
Non-small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Small Cell Lung Cancer, Renal Cell Carcinoma, Colorectal Carcinoma, Triple-Negative Breast Cancer, Squamous Cell Carcinoma Of The Head And Neck
Phase I
Recruiting
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
Mar 14, 2023
―
Darolutamide, Janx007
Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Castration Resistant Prostatic Cancer
Phase I
Recruiting
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Aug 25, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Janux Therapeutics Inc (JANX) have in its pipeline
JANX is currently developing the following drugs: Janx008, Darolutamide, Janx007. These drug candidates are in various stages of clinical development as the company works toward FDA approval.